The variable part of the income is based on that the company reaches certain predetermined results.
All members of the executive management have a variable income not exceeding 40 per cent of the fixed yearly income. 75 per cent of the variable salary is dependent on the company achieving certain predetermined results. The remaining 25 per cent of the variable salary is base upon predetermined criteria related to personal performance.
The Board of Directors has the possibility to resolve that an additional discretionary bonus shall be paid to the members of the executive management, including the CEO. The conditions for payment of the discretionary bonus shall be of extraordinary character.
Conditions for variable income and performance criteria – The Board of Directors may at its own discretion determine the conditions for payment of variable income.
At the AGM held on June 4, 2020, the shareholders resolved to authorize the Board of Directors to implement a share based incentive program as outlined in the notice for the AGM.
The Compensation Committee meet when so is required and attend to matters relating to salaries, other employment conditions, pension benefits and bonus for the CEO and members of the Management team that reports directly to the CEO, as well as other compensation matters of principal interest.
Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development and diagnostics, analytical testing and water and environmental testing.
Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited.
Our customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.
Biotage is headquartered in Uppsala in Sweden and employs over 500 people worldwide. The Group had sales of 1,566 MSEK in 2022 and our products are sold in more than 80 countries. Biotage’s share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm.
Copyright © 2023 Biotage
Biotage är ett Globalt Impact Tech företag som är djupt engagerade i att lösa samhällsproblem. Vi erbjuder lösningar för kunders arbetsflöden inom forskning och tillverkning av läkemedel och diagnostik, analytisk testning och vatten- och miljöanalyser.
Biotage bidrar till hållbar vetenskap och vi strävar efter att göra världen mer hälsosam, grönare och renare för mänskligheten – HumanKind Unlimited.
Våra kunder spänner över ett brett spektrum av marknadssegment från läkemedel, bioteknik, diagnostik, kontraktsforskning och kontraktstillverkning till kliniska, forensiska och akademiska laboratorier liksom organisationer som fokuserar på livsmedelssäkerhet, rent vatten och miljömässig hållbarhet.
Biotage har huvudkontor i Uppsala, Sverige, och har 497 anställda världen över. Koncernen hade en försäljning på 1 232 miljoner kronor 2021 och våra produkter säljs i mer än 80 länder. Biotages aktie (BIOT) är noterad på NASDAQ Stockholm, Large Cap.
Copyright © 2020 Biotage
SEL-2EV
Two Channel, Extended Collection Bed, UV Detector